GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Global Bio-chem Technology Group Co Ltd (HKSE:00809) » Definitions » Cash Flow from Financing

Global Bio-chem Technology Group Co (HKSE:00809) Cash Flow from Financing : HK$113 Mil (TTM As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Global Bio-chem Technology Group Co Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2023, Global Bio-chem Technology Group Co paid HK$0 Mil more to buy back shares than it received from issuing new shares. It spent HK$8 Mil paying down its debt. It paid HK$0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received HK$0 Mil from paying cash dividends to shareholders. It spent HK$48 Mil on other financial activities. In all, Global Bio-chem Technology Group Co spent HK$56 Mil on financial activities for the six months ended in Dec. 2023.


Global Bio-chem Technology Group Co Cash Flow from Financing Historical Data

The historical data trend for Global Bio-chem Technology Group Co's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Bio-chem Technology Group Co Cash Flow from Financing Chart

Global Bio-chem Technology Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -456.92 -25.87 -48.66 109.75 112.62

Global Bio-chem Technology Group Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.25 -30.31 140.06 169.92 -57.30

Global Bio-chem Technology Group Co Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Global Bio-chem Technology Group Co's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Global Bio-chem Technology Group Co's Cash from Financing for the quarter that ended in Dec. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$113 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Global Bio-chem Technology Group Co  (HKSE:00809) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Global Bio-chem Technology Group Co's issuance of stock for the six months ended in Dec. 2023 was HK$0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Global Bio-chem Technology Group Co's repurchase of stock for the six months ended in Dec. 2023 was HK$0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Global Bio-chem Technology Group Co's net issuance of debt for the six months ended in Dec. 2023 was HK$-8 Mil. Global Bio-chem Technology Group Co spent HK$8 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Global Bio-chem Technology Group Co's net issuance of preferred for the six months ended in Dec. 2023 was HK$0 Mil. Global Bio-chem Technology Group Co paid HK$0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Global Bio-chem Technology Group Co's cash flow for dividends for the six months ended in Dec. 2023 was HK$0 Mil. Global Bio-chem Technology Group Co received HK$0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Global Bio-chem Technology Group Co's other financing for the six months ended in Dec. 2023 was HK$-48 Mil. Global Bio-chem Technology Group Co spent HK$48 Mil on other financial activities.


Global Bio-chem Technology Group Co Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Global Bio-chem Technology Group Co's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Bio-chem Technology Group Co (HKSE:00809) Business Description

Traded in Other Exchanges
N/A
Address
18 Hung Luen Road, Suite 1002, 10th Floor, Tower A, Cheung Kei Center, Hung Hom, Kowloon, Hong Kong, HKG
Global Bio-chem Technology Group Co Ltd manufactures and sells corn-refined products and corn-based biochemical products. Its segments are the Upstream Products segment engages in the manufacture and sale of corn starch, gluten meal, corn oil, and other corn refined products; the Amino Acids segment engages in the manufacture and sale of corn-based biochemical products, including lysine and threonine; the Corn Sweeteners segment engages in the manufacture and sale of corn-based sweetener products, including glucose, maltose, high fructose corn syrup, crystallized glucose, and maltodextrin; the Polyol Chemicals segment engages in the manufacture and sale of corn-based biochemical products, including polyol chemicals, anti-freeze products, hydrogen, and ammonia.
Executives
Ji Lin Sheng Ren Min Zheng Fu Guo You Zi Chan Jian Du Guan Li Wei Yuan Hui 2201 Interest of corporation controlled by you
Ji Lin Sheng Yuan Heng Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Ji Lin Sheng Li Heng Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Ji Lin Zhang Bai Shan Gu Quan Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Ji Lin Sheng Xian Dai Nong Ye Chan Ye Ji Jin You Xian Gong Si 2201 Interest of corporation controlled by you
Ji Lin Sheng Nong Ye Tou Zi Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Zhong Guo Min Sheng Tou Zi Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Rationale (holdings) Investment Limited 2101 Beneficial owner
Zhong Min Xin Neng Tou Zi Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Rui Xuan Tou Zi Shang Hai You Xian Gong Si 2201 Interest of corporation controlled by you
Bank Of Jilin Co., Ltd. 2106 Person having a security interest in shares
Sun Zhen 2201 Interest of corporation controlled by you
Modern Agricultural Industry Investment Holdings Limited 2201 Interest of corporation controlled by you
Ji Lin Sheng Xian Dai Nong Ye Chan Ye Tou Zi Ji Jin You Xian He Huo 2201 Interest of corporation controlled by you
Li Zhenghao 2201 Interest of corporation controlled by you

Global Bio-chem Technology Group Co (HKSE:00809) Headlines

No Headlines